PRE 14A

PROXY STATEMENT

Company: Cadrenal Therapeutics, Inc.
Filed: May 29, 2024
Period of Report: May 29, 2024
Accession Number: 0001213900-24-047553

View Document ↗ View on SEC.gov ↗